Full-Time

Lab Equipment and Automation Support Engineering Manager

Posted on 5/16/2026

LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

Compensation Overview

$100k - $138k/yr

San Francisco, CA, USA

In Person

Category
Biology & Biotech (1)
Requirements
  • Bachelor's degree
  • 3 years or more experience in a high complexity lab environment as an operator, lab technician, lab assistant, lab automation support engineer, or lab equipment support role
  • 3 years or more experience in equipment support
Responsibilities
  • Lead, train, mentor and support a team of Production Support Engineers that provide troubleshooting support for all hardware and software in a high automated diagnostics molecular laboratory
  • Drive continuous process improvement programs including management of assets, in line production line metrics; up time, down time, utilization - volumes/capacity. Oversee hiring, coaching, and mentoring of staff
  • Maintain oversight for quality of work performed and appropriate documentation
  • Ensure appropriate hand-off communication and work completion between shifts
  • Ensure all standard operating procedures (SOPs) are current and revised when necessary
  • Support troubleshooting of down systems when an immediate resolution is not available and utilize escalation pathways to expedite securing of resources as needed
  • Ensure all production line support operations are conducted in a timely manner with the meeting quality standards; i.e., laboratory equipment maintenance and first tier software and hardware support
  • Manage team schedules to ensure sufficient staffing
  • Communicate to the Clinical Production Laboratory team the status of production line equipment and any other essential or pertinent information
  • Aid in the transfer of new technologies or changes to existing technologies into the production
  • Ensure all training and competencies are completed on time for all staff
  • Monitor and review with the staff, key performance indicators/dashboards and assess for continuous improvement.
Desired Qualifications
  • Bachelor’s degree in Engineering or Life Sciences
  • 2 years or more experience managing and leading a technical team or technical project
  • 2 years or more Field Service Engineering experience for relevant manufacturers such as Agilent, Hamilton, Dynamic Devices, Tecan, Illumina, Unchained Labs
  • 2 years or more experience with automated Next Generation Sequencing (NGS) workflows, including sample prep, extraction, quant/norm/pool, library prep, hyb/target capture, sequencing
  • 2 years or more experience with basic programming and following programming logic and understanding pseudo-coding
  • 2 years or more experience qualifying and deploying laboratory equipment in a production environment
  • 2 years or more experience with conducting causal analysis and implementing corrective actions plans
  • 2 years or more experience developing and monitoring equipment operational metrics

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Epic integration can accelerate hospital onboarding and drive higher test volumes.
  • Specialty testing growth in oncology and neurology supports higher-margin revenue expansion.
  • Plasma Detect Genome MRD and Fox Chase broaden oncology utility beyond colon cancer.

What critics are saying

  • Epic Aura also hosts Quest Diagnostics, eroding Labcorp's workflow differentiation quickly.
  • Plasma Detect Genome MRD remains unproven in lung cancer until observational utility data arrives.
  • Consumer AI errors or privacy issues in MyLabcorp would damage trust and adoption.

What makes LabCorp unique

  • Labcorp spans diagnostics and biopharma services, unlike pure-play lab peers.
  • Its May 2026 Epic Aura expansion embeds Labcorp's full menu inside EHR workflows.
  • MyLabcorp turns lab results into AI-guided trends for consumers.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at LabCorp who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

ChemXpert
May 15th, 2026
Labcorp expands Epic collaboration to integrate full diagnostic test menu through Aura platform.

Labcorp expands Epic collaboration to integrate full diagnostic test menu through Aura platform. Labcorp has announced an expanded collaboration with Epic Systems aimed at improving how hospitals and health systems access laboratory testing services through electronic health record (EHR) workflows. Under the expanded agreement, Labcorp's full diagnostic test menu will become available through Epic's Aura platform, enabling clinicians to order tests and receive results directly within existing Epic workflows. The move is expected to simplify laboratory integrations, reduce operational complexity for health systems and improve access to advanced diagnostics nationwide. What the expanded collaboration includes? The integration builds on the existing availability of Invitae genetic tests through Epic Aura. With the expansion, hospitals and health systems using Epic will gain access to: * Labcorp's full diagnostic testing menu * Newly introduced laboratory tests * Advanced and specialty diagnostics * Integrated ordering and reporting workflows According to the companies, the collaboration is designed to streamline the process of connecting healthcare systems with external laboratory providers. Reducing IT complexity for health systems. Healthcare organizations often face significant technical and operational challenges when integrating laboratory systems with EHR platforms. These projects can involve: * Lengthy onboarding timelines * High implementation costs * Complex interface management * Ongoing maintenance requirements By leveraging Epic's Aura platform, the companies say the integration will reduce much of that burden through standardized connectivity and centralized content management. The goal is to shorten implementation timelines while minimizing maintenance and administrative overhead for hospitals and health systems. Seamless lab ordering within clinical workflows. One of the key advantages of the expanded integration is improved workflow efficiency for clinicians and care teams. Through Aura, clinicians will be able to: * Order Labcorp tests directly within Epic * Receive discrete laboratory results inside patient records * Reduce manual data entry * Minimize workflow disruptions and workarounds The integration is intended to help clinicians order appropriate tests more efficiently while improving access to diagnostic information within routine patient care workflows. Improving Access to advanced diagnostics. The collaboration also expands access to Labcorp's evolving portfolio of advanced diagnostics and specialty testing services. According to Labcorp, health systems using Epic will be able to access new tests as they are introduced without requiring separate integration projects. This could be particularly valuable in areas such as: * Genetic testing * Precision medicine * Oncology diagnostics * Specialized biomarker testing * Rare disease screening Leadership perspectives. Bryan Vaughn, executive vice president and president of Diagnostics at Labcorp, said the expanded collaboration reflects the company's broader strategy of supporting the changing needs of hospitals and health systems. According to Vaughn, simplifying laboratory integration while embedding Labcorp's test menu directly into Epic workflows creates a stronger foundation for future diagnostic innovation. Meanwhile, Sumit Rana, president of Epic Systems, stated that the expanded use of Aura will help clinicians order the correct tests more efficiently and enable patients to receive faster diagnostic answers. Why this matters? Laboratory diagnostics play a critical role in modern healthcare decision-making, but fragmented systems and disconnected workflows often create inefficiencies for providers. The expanded Labcorp-Epic integration addresses several major industry challenges, including: * Interoperability between laboratories and EHR systems * Administrative burden on healthcare providers * Delays in diagnostic workflows * Access to advanced testing capabilities As healthcare systems increasingly prioritize integrated digital workflows and precision medicine, partnerships between laboratory providers and EHR companies are becoming strategically important. Growing importance of ehr-integrated diagnostics. The collaboration also highlights a broader trend toward tighter integration between diagnostics companies and healthcare technology platforms. By embedding laboratory services directly within clinical workflows, healthcare organizations aim to: * Improve care coordination * Reduce operational inefficiencies * Accelerate diagnostic decision-making * Enhance patient outcomes For Labcorp, the partnership further strengthens its position in the rapidly evolving digital diagnostics ecosystem, while expanding the reach of its testing portfolio across hospitals and health systems using Epic nationwide.

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

INACTIVE